NANOG, a downstream target of OCT-4, contributes to cell fate determination of the pluripotent inner cell mass during embryonic development [32]. It promotes CSC characteristics in prostate cancer and regulates the self-renewal of CSC in human hepatocellular carcinoma (HCC) [33]. Here, NANOG is linked to prostate cancer.